Practices and perceptions around splitting of carbidopa/levodopa tablets: a survey of patients and neurologists
Pill splitting is common but burdensome and imprecise. Further research is needed to evaluate clinical impact.
Authors
- Rajesh Pahwa (ORCID: https://orcid.org/0000-0003-3176-6466)
- Ramon L. Rodriguez (ORCID: https://orcid.org/0009-0008-8005-9200)
- Yasar Torres‐Yaghi (ORCID: https://orcid.org/0000-0002-9676-3832)
- Stuart Isaacson (ORCID: https://orcid.org/0000-0002-9914-5706)
- Ahmad Al‐Sabbagh
- David Holecek
Institutions
- Georgetown University (US)
- MedStar Georgetown University Hospital (US)
- EP Analytics (United States) (US)
- Parkinson's Research and Education Foundation (US)
- Avanir Pharmaceuticals (United States) (US)
- University of Kansas Medical Center (US)
Publication Details
- Journal
- Neurodegenerative Disease Management
- Published
- 2025-12-03
- DOI
- https://doi.org/10.1080/17582024.2025.2577054
- Primary Topic
- Pharmaceutical studies and practices
- Type
- article
- Field-Weighted Citation Impact
- 0.00